nach oben

European Journal of Nutrition

Erschienen in:

29.01.2021 | Review

Impacts of gut microbiota on gestational diabetes mellitus: a comprehensive review

verfasst von: Lingling Huang, Chanisa Thonusin, Nipon Chattipakorn, Siriporn C. Chattipakorn

Erschienen in: European Journal of Nutrition | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Gestational diabetes mellitus (GDM) is a condition that seriously threatens mother and child health. The incidence of GDM has increased worldwide in the past decades. In addition, the complications of GDM such as type 2 diabetes (T2DM) and neonatal malformations could negatively affect the living quality of mothers and their children.

Aim

It has been widely known that the imbalance of gut microbiota or called ‘gut dysbiosis’ plays a key role in the development of insulin resistance and chronic low-grade inflammation in T2DM patients. However, the impacts of gut microbiota on GDM remain controversial. Here, we aim to comprehensively review the alterations of gut microbiota in GDM mothers and their offspring.

Results

The alterations of Firmicutes/Bacteroidetes (F/B) ratio, short-chain fatty acid (SCFA)-producing bacteria, bacteria with probiotics properties and gram-negative lipopolysaccharide (LPS)-producing bacteria play a vital role in the development of GDM. The beneficial roles of gut microbiota modification (probiotics, synbiotics and lifestyle modification) as a treatment of GDM were found in some, but not all studies.

Conclusion

In the near future, gut microbiota modification may be considered as one of the standard treatments for GDM. Moreover, further studies regarding the specific gut microbiota that are associated with the early development of GDM are required. This may contribute to the novel diagnostic markers for early stages of GDM.

Weinert LS (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy: comment to the International Association of Diabetes and Pregnancy Study Groups Consensus Panel. Diabetes Care 33(7):e97–e97. https://doi.org/10.2337/dc10-0544CrossRefPubMed

McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P (2019) Gestational diabetes mellitus. Nat Rev Dis Primers 5(1):47. https://doi.org/10.1038/s41572-019-0098-8CrossRefPubMed

Daly B, Toulis KA, Thomas N, Gokhale K, Martin J, Webber J, Keerthy D, Jolly K, Saravanan P, Nirantharakumar K (2018) Increased risk of ischemic heart disease, hypertension, and type 2 diabetes in women with previous gestational diabetes mellitus, a target group in general practice for preventive interventions: a population-based cohort study. PLoS Med 15(1):e1002488. https://doi.org/10.1371/journal.pmed.1002488CrossRefPubMedPubMedCentral

Li L-J, Tan KH, Aris IM, Man REK, Gan ATL, Chong YS, Saw SM, Gluckman P, Wong TY, Lamoureux E (2018) Retinal vasculature and 5-year metabolic syndrome among women with gestational diabetes mellitus. Metabolism 83:216–224. https://doi.org/10.1016/j.metabol.2017.10.004CrossRefPubMed

Grandi SM, Filion KB, Yoon S, Ayele HT, Doyle CM, Hutcheon JA, Smith GN, Gore GC, Ray JG, Nerenberg K, Platt RW (2019) Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications. Circulation 139(8):1069–1079. https://doi.org/10.1161/circulationaha.118.036748CrossRefPubMed

Hod M, Kapur A, McIntyre HD, PoeN C (2019) Evidence in support of the international association of diabetes in pregnancy study groups’ criteria for diagnosing gestational diabetes mellitus worldwide in 2019. Am J Obstet Gynecol 221(2):109–116. https://doi.org/10.1016/j.ajog.2019.01.206CrossRefPubMed

Huynh J, Xiong G, Bentley-Lewis R (2014) A systematic review of metabolite profiling in gestational diabetes mellitus. Diabetologia 57(12):2453–2464. https://doi.org/10.1007/s00125-014-3371-0CrossRefPubMedPubMedCentral

Schneider S, Hoeft B, Freerksen N, Fischer B, Roehrig S, Yamamoto S, Maul H (2010) Neonatal complications and risk factors among women with gestational diabetes mellitus. Acta Obstet Gynecol Scand. https://doi.org/10.1111/j.1600-0412.2010.01040.xCrossRefPubMed

Lowe WL, Scholtens DM, Kuang A, Linder B, Lawrence JM, Lebenthal Y, McCance D, Hamilton J, Nodzenski M, Talbot O, Brickman WJ, Clayton P, Ma RC, Tam WH, Dyer AR, Catalano PM, Lowe LP, Metzger BE (2019) Hyperglycemia and adverse pregnancy outcome follow-up study (hapo fus): maternal gestational diabetes mellitus and childhood glucose metabolism. Diabetes Care 42(3):372–380. https://doi.org/10.2337/dc18-1646CrossRefPubMedPubMedCentral

10.

Vohr BR, Boney CM (2008) Gestational diabetes: the forerunner for the development of maternal and childhood obesity and metabolic syndrome? J Maternal-Fetal Neonatal Med 21(3):149–157. https://doi.org/10.1080/14767050801929430CrossRef

11.

Xiang AH, Wang X, Martinez MP, Walthall JC, Curry ES, Page K, Buchanan TA, Coleman KJ, Getahun D (2015) Association of maternal diabetes with autism in offspring. JAMA 313(14):1425–1434CrossRef

12.

Maschirow L, Suttorp N, Opitz B (2019) Microbiota-dependent regulation of antimicrobial immunity in the lung. Am J Respir Cell Mol Biol 61(3):284–289. https://doi.org/10.1165/rcmb.2019-0101TRCrossRefPubMed

13.

Li F, Chen C, Wei W, Wang Z, Dai J, Hao L, Song L, Zhang X, Zeng L, Du H, Tang H, Liu N, Yang H, Wang J, Madsen L, Brix S, Kristiansen K, Xu X, Li J, Wu R, Jia H (2018) The metagenome of the female upper reproductive tract. Gigascience 7:10. https://doi.org/10.1093/gigascience/giy107CrossRef

14.

Barr JJ (2017) A bacteriophages journey through the human body. Immunol Rev 279(1):106–122. https://doi.org/10.1111/imr.12565CrossRefPubMed

15.

Quan LH, Zhang C, Dong M, Jiang J, Xu H, Yan C, Liu X, Zhou H, Zhang H, Chen L, Zhong FL, Luo ZB, Lam SM, Shui G, Li D, Jin W (2019) Myristoleic acid produced by enterococci reduces obesity through brown adipose tissue activation. Gut. https://doi.org/10.1136/gutjnl-2019-319114CrossRefPubMed

16.

Alipour M, Zaidi D, Valcheva R, Jovel J, Martínez I, Sergi C, Walter J, Mason AL, Wong GK-S, Dieleman LA, Carroll MW, Huynh HQ, Wine E (2016) Mucosal barrier depletion and loss of bacterial diversity are primary abnormalities in paediatric ulcerative colitis. J Crohn’s Colitis 10(4):462–471. https://doi.org/10.1093/ecco-jcc/jjv223CrossRef

17.

Dalby MJ, Ross AW, Walker AW, Morgan PJ (2017) Dietary uncoupling of gut microbiota and energy harvesting from obesity and glucose tolerance in mice. Cell Rep 21(6):1521–1533. https://doi.org/10.1016/j.celrep.2017.10.056CrossRefPubMedPubMedCentral

18.

Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, Wu S, Liu W, Cui Q, Geng B, Zhang W, Weldon R, Auguste K, Yang L, Liu X, Chen L, Yang X, Zhu B, Cai J (2017) Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome 5(1):14. https://doi.org/10.1186/s40168-016-0222-xCrossRefPubMedPubMedCentral

19.

Wang X, Sun G, Feng T, Zhang J, Huang X, Wang T, Xie Z, Chu X, Yang J, Wang H, Chang S, Gong Y, Ruan L, Zhang G, Yan S, Lian W, Du C, Yang D, Zhang Q, Lin F, Liu J, Zhang H, Ge C, Xiao S, Ding J, Geng M (2019) Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit alzheimer’s disease progression. Cell Res 29(10):787–803. https://doi.org/10.1038/s41422-019-0216-xCrossRefPubMedPubMedCentral

20.

Gopalakrishnan V, Helmink BA, Spencer CN, Reuben A, Wargo JA (2018) The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy. Cancer Cell 33(4):570–580. https://doi.org/10.1016/j.ccell.2018.03.015CrossRefPubMedPubMedCentral

21.

Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, Backhed HK, Gonzalez A, Werner JJ, Angenent LT, Knight R, Backhed F, Isolauri E, Salminen S, Ley RE (2012) Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 150(3):470–480. https://doi.org/10.1016/j.cell.2012.07.008CrossRefPubMedPubMedCentral

22.

Wang J, Zheng J, Shi W, Du N, Xu X, Zhang Y, Ji P, Zhang F, Jia Z, Wang Y, Zheng Z, Zhang H, Zhao F (2018) Dysbiosis of maternal and neonatal microbiota associated with gestational diabetes mellitus. Gut 67(9):1614–1625. https://doi.org/10.1136/gutjnl-2018-315988CrossRefPubMed

23.

Ponzo V, Ferrocino I, Zarovska A, Amenta MB, Leone F, Monzeglio C, Rosato R, Pellegrini M, Gambino R, Cassader M (2019) The microbiota composition of the offspring of patients with gestational diabetes mellitus (gdm). PLoS ONE 14(12):e0226545. https://doi.org/10.1371/journal.pone.0226545CrossRefPubMedPubMedCentral

24.

Kuang YS, Lu JH, Li SH, Li JH, Yuan MY, He JR, Chen NN, Xiao WQ, Shen SY, Qiu L, Wu YF, Hu CY, Wu YY, Li WD, Chen QZ, Deng HW, Papasian CJ, Xia HM, Qiu X (2017) Connections between the human gut microbiome and gestational diabetes mellitus. Gigascience 6(8):1–12. https://doi.org/10.1093/gigascience/gix058CrossRefPubMedPubMedCentral

25.

Liu H, Pan LL, Lv S, Yang Q, Zhang H, Chen W, Lv Z, Sun J (2019) Alterations of gut microbiota and blood lipidome in gestational diabetes mellitus with hyperlipidemia. Front Physiol 10:1015. https://doi.org/10.3389/fphys.2019.01015CrossRefPubMedPubMedCentral

26.

Liu Y, Qin S, Feng Y, Song Y, Lv N, Liu F, Zhang X, Wang S, Wei Y, Li S, Su S, Zhang W, Xue Y, Hao Y, Zhu B, Ma J, Yang H (2020) Perturbations of gut microbiota in gestational diabetes mellitus patients induce hyperglycemia in germ-free mice. J Dev Orig Health Dis 11(6):580–588. https://doi.org/10.1017/S2040174420000768CrossRefPubMed

27.

Nuli R, Cai J, Kadeer A, Zhang Y, Mohemaiti P (2019) Integrative analysis toward different glucose tolerance-related gut microbiota and diet. Front Endocrinol (Lausanne) 10:295. https://doi.org/10.3389/fendo.2019.00295CrossRef

28.

Kaplan RC, Wang Z, Usyk M, Sotres-Alvarez D, Daviglus ML, Schneiderman N, Talavera GA, Gellman MD, Thyagarajan B, Moon JY, Vazquez-Baeza Y, McDonald D, Williams-Nguyen JS, Wu MC, North KE, Shaffer J, Sollecito CC, Qi Q, Isasi CR, Wang T, Knight R, Burk RD (2019) Gut microbiome composition in the hispanic community health study/study of latinos is shaped by geographic relocation, environmental factors, and obesity. Genome Biol 20(1):219. https://doi.org/10.1186/s13059-019-1831-zCrossRefPubMedPubMedCentral

29.

Crusell MKW, Hansen TH, Nielsen T, Allin KH, Rühlemann MC, Damm P, Vestergaard H, Rørbye C, Jørgensen NR, Christiansen OB, Heinsen F-A, Franke A, Hansen T, Lauenborg J, Pedersen O (2018) Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum. Microbiome. https://doi.org/10.1186/s40168-018-0472-xCrossRefPubMedPubMedCentral

30.

Wu Y, Bible PW, Long S, Ming WK, Ding W, Long Y, Wen X, Li X, Deng X, Deng Y, Guo S, Doci CL, Wei L, Chen H, Wang Z (2020) Metagenomic analysis reveals gestational diabetes mellitus-related microbial regulators of glucose tolerance. Acta Diabetol 57(5):569–581. https://doi.org/10.1007/s00592-019-01434-2CrossRefPubMed

31.

Xu Y, Zhang M, Zhang J, Sun Z, Ran L, Ban Y, Wang B, Hou X, Zhai S, Ren L, Wang M, Hu J (2019) Differential intestinal and oral microbiota features associated with gestational diabetes and maternal inflammation. Am J Physiol Endocrinol Metab. https://doi.org/10.1152/ajpendo.00266.2019CrossRefPubMedPubMedCentral

32.

Ye G, Zhang L, Wang M, Chen Y, Gu S, Wang K, Leng J, Gu Y, Xie X (2019) The gut microbiota in women suffering from gestational diabetes mellitus with the failure of glycemic control by lifestyle modification. J Diabetes Res 2019:6081248. https://doi.org/10.1155/2019/6081248CrossRefPubMedPubMedCentral

33.

Zheng W, Xu Q, Huang W, Yan Q, Chen Y, Zhang L, Tian Z, Liu T, Yuan X, Liu C, Luo J, Guo C, Song W, Zhang L, Liang X, Qin H, Li G (2020) Gestational diabetes mellitus is associated with reduced dynamics of gut microbiota during the first half of pregnancy. mSystems. https://doi.org/10.1128/mSystems.00109-20CrossRefPubMedPubMedCentral

34.

Cortez RV, Taddei CR, Sparvoli LG, Ângelo AG, Padilha M, Mattar R, Daher S (2019) Microbiome and its relation to gestational diabetes. Endocrine 64(2):254–264. https://doi.org/10.1007/s12020-018-1813-zCrossRefPubMed

35.

Huse SM, Ye Y, Zhou Y, Fodor AA (2012) A core human microbiome as viewed through 16s rrna sequence clusters. PLoS ONE 7(6):e34242. https://doi.org/10.1371/journal.pone.0034242CrossRefPubMedPubMedCentral

36.

Roselli M, Devirgiliis C, Zinno P, Guantario B, Finamore A, Rami R, Perozzi G (2017) Impact of supplementation with a food-derived microbial community on obesity-associated inflammation and gut microbiota composition. Genes Nutr 12:25. https://doi.org/10.1186/s12263-017-0583-1CrossRefPubMedPubMedCentral

37.

Pascale A, Marchesi N, Govoni S, Coppola A, Gazzaruso C (2019) The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: new insights into old diseases. Curr Opin Pharmacol 49:1–5CrossRef

38.

Gloria YC, Latz E, De Nardo D (2018) Generation of innate immune reporter cells using retroviral transduction. In: Innate immune activation. Springer, pp 97–117. https://doi.org/10.1007/978-1-4939-7519-8_7

39.

Rosadini CV, Kagan JC (2017) Early innate immune responses to bacterial lps. Curr Opin Immunol 44:14–19CrossRef

40.

Larraufie P, Martin-Gallausiaux C, Lapaque N, Dore J, Gribble FM, Reimann F, Blottiere HM (2018) Scfas strongly stimulate pyy production in human enteroendocrine cells. Sci Rep 8(1):74. https://doi.org/10.1038/s41598-017-18259-0CrossRefPubMedPubMedCentral

41.

Roshanravan N, Mahdavi R, Alizadeh E, Jafarabadi MA, Hedayati M, Ghavami A, Alipour S, Alamdari NM, Barati M, Ostadrahimi A (2017) Effect of butyrate and inulin supplementation on glycemic status, lipid profile and glucagon-like peptide 1 level in patients with type 2 diabetes: a randomized double-blind, placebo-controlled trial. Horm Metab Res 49(11):886–891. https://doi.org/10.1055/s-0043-119089CrossRefPubMed

42.

Liu H, Wang J, He T, Becker S, Zhang G, Li D, Ma X (2018) Butyrate: a double-edged sword for health? Adv Nutr 9(1):21–29. https://doi.org/10.1093/advances/nmx009CrossRefPubMedPubMedCentral

43.

Hasan AU, Rahman A, Kobori H (2019) Interactions between host ppars and gut microbiota in health and disease. Int J Mol Sci. https://doi.org/10.3390/ijms20020387CrossRefPubMedPubMedCentral

44.

Vinolo MA, Rodrigues HG, Hatanaka E, Sato FT, Sampaio SC, Curi R (2011) Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J Nutr Biochem 22(9):849–855. https://doi.org/10.1016/j.jnutbio.2010.07.009CrossRefPubMed

45.

Liu T, Li J, Liu Y, Xiao N, Suo H, Xie K, Yang C, Wu C (2012) Short-chain fatty acids suppress lipopolysaccharide-induced production of nitric oxide and proinflammatory cytokines through inhibition of nf-kappab pathway in raw264.7 cells. Inflammation 35(5):1676–1684. https://doi.org/10.1007/s10753-012-9484-zCrossRefPubMed

46.

Parada Venegas D, De la Fuente MK, Landskron G, Gonzalez MJ, Quera R, Dijkstra G, Harmsen HJM, Faber KN, Hermoso MA (2019) Short chain fatty acids (scfas)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol 10:277. https://doi.org/10.3389/fimmu.2019.00277CrossRefPubMedPubMedCentral

47.

Canfora EE, Meex RCR, Venema K, Blaak EE (2019) Gut microbial metabolites in obesity, nafld and t2dm. Nat Rev Endocrinol 15(5):261–273. https://doi.org/10.1038/s41574-019-0156-zCrossRefPubMed

48.

Natividad JM, Agus A, Planchais J, Lamas B, Jarry AC, Martin R, Michel ML, Chong-Nguyen C, Roussel R, Straube M, Jegou S, McQuitty C, Le Gall M, da Costa G, Lecornet E, Michaudel C, Modoux M, Glodt J, Bridonneau C, Sovran B, Dupraz L, Bado A, Richard ML, Langella P, Hansel B, Launay JM, Xavier RJ, Duboc H, Sokol H (2018) Impaired aryl hydrocarbon receptor ligand production by the gut microbiota is a key factor in metabolic syndrome. Cell Metab 28(5):737-749.e734. https://doi.org/10.1016/j.cmet.2018.07.001CrossRefPubMed

49.

Soderholm AT, Pedicord VA (2019) Intestinal epithelial cells: at the interface of the microbiota and mucosal immunity. Immunology 158(4):267–280. https://doi.org/10.1111/imm.13117CrossRefPubMedPubMedCentral

50.

Scott SA, Fu J, Chang PV (2020) Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor. Proc Natl Acad Sci USA 117(32):19376–19387. https://doi.org/10.1073/pnas.2000047117CrossRefPubMedPubMedCentral

51.

Sichetti M, De Marco S, Pagiotti R, Traina G, Pietrella D (2018) Anti-inflammatory effect of multistrain probiotic formulation (L. rhamnosus, B. lactis, and B. longum). Nutrition 53:95–102. https://doi.org/10.1016/j.nut.2018.02.005CrossRefPubMed

52.

Wang G, Li X, Zhao J, Zhang H, Chen W (2017) Lactobacillus casei ccfm419 attenuates type 2 diabetes via a gut microbiota dependent mechanism. Food Funct 8(9):3155–3164. https://doi.org/10.1039/c7fo00593hCrossRefPubMed

53.

Tamtaji OR, Kouchaki E, Salami M, Aghadavod E, Akbari E, Tajabadi-Ebrahimi M, Asemi Z (2017) The effects of probiotic supplementation on gene expression related to inflammation, insulin, and lipids in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial. J Am Coll Nutr 36(8):660–665. https://doi.org/10.1080/07315724.2017.1347074CrossRefPubMed

54.

Krumbeck JA, Rasmussen HE, Hutkins RW, Clarke J, Shawron K, Keshavarzian A, Walter J (2018) Probiotic bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics. Microbiome 6(1):121. https://doi.org/10.1186/s40168-018-0494-4CrossRefPubMedPubMedCentral

55.

Ma S, You Y, Huang L, Long S, Zhang J, Guo C, Zhang N, Wu X, Xiao Y, Tan H (2020) Alterations in gut microbiota of gestational diabetes patients during the first trimester of pregnancy. Front Cell Infect Microbiol 10:58. https://doi.org/10.3389/fcimb.2020.00058CrossRefPubMedPubMedCentral

56.

Mokkala K, Paulin N, Houttu N, Koivuniemi E, Pellonpera O, Khan S, Pietila S, Tertti K, Elo LL, Laitinen K (2020) Metagenomics analysis of gut microbiota in response to diet intervention and gestational diabetes in overweight and obese women: a randomised, double-blind, placebo-controlled clinical trial. Gut. https://doi.org/10.1136/gutjnl-2020-321643CrossRefPubMed

57.

Ferrocino I, Ponzo V, Gambino R, Zarovska A, Leone F, Monzeglio C, Goitre I, Rosato R, Romano A, Grassi G, Broglio F, Cassader M, Cocolin L, Bo S (2018) Changes in the gut microbiota composition during pregnancy in patients with gestational diabetes mellitus (gdm). Sci Rep 8(1):12216. https://doi.org/10.1038/s41598-018-30735-9CrossRefPubMedPubMedCentral

58.

Fugmann M, Breier M, Rottenkolber M, Banning F, Ferrari U, Sacco V, Grallert H, Parhofer KG, Seissler J, Clavel T, Lechner A (2015) The stool microbiota of insulin resistant women with recent gestational diabetes, a high risk group for type 2 diabetes. Sci Rep 5:13212. https://doi.org/10.1038/srep13212CrossRefPubMedPubMedCentral

59.

Su M, Nie Y, Shao R, Duan S, Jiang Y, Wang M, Xing Z, Sun Q, Liu X, Xu W (2018) Diversified gut microbiota in newborns of mothers with gestational diabetes mellitus. PLoS ONE 13(10):e0205695. https://doi.org/10.1371/journal.pone.0205695CrossRefPubMedPubMedCentral

60.

Thiennimitr P, Yasom S, Tunapong W, Chunchai T, Wanchai K, Pongchaidecha A, Lungkaphin A, Sirilun S, Chaiyasut C, Chattipakorn N, Chattipakorn SC (2018) Lactobacillus paracasei hii01, xylooligosaccharides, and synbiotics reduce gut disturbance in obese rats. Nutrition 54:40–47. https://doi.org/10.1016/j.nut.2018.03.005CrossRefPubMed

61.

Kobyliak N, Falalyeyeva T, Mykhalchyshyn G, Kyriienko D, Komissarenko I (2018) Effect of alive probiotic on insulin resistance in type 2 diabetes patients: randomized clinical trial. Diabetes Metab Syndr 12(5):617–624. https://doi.org/10.1016/j.dsx.2018.04.015CrossRefPubMed

62.

Simon MC, Strassburger K, Nowotny B, Kolb H, Nowotny P, Burkart V, Zivehe F, Hwang JH, Stehle P, Pacini G, Hartmann B, Holst JJ, MacKenzie C, Bindels LB, Martinez I, Walter J, Henrich B, Schloot NC, Roden M (2015) Intake of lactobacillus reuteri improves incretin and insulin secretion in glucose-tolerant humans: a proof of concept. Diabetes Care 38(10):1827–1834. https://doi.org/10.2337/dc14-2690CrossRefPubMed

63.

Mobini R, Tremaroli V, Stahlman M, Karlsson F, Levin M, Ljungberg M, Sohlin M, Berteus Forslund H, Perkins R, Backhed F, Jansson PA (2017) Metabolic effects of Lactobacillus reuteri dsm 17938 in people with type 2 diabetes: a randomized controlled trial. Diabetes Obes Metab 19(4):579–589. https://doi.org/10.1111/dom.12861CrossRefPubMed

64.

Karamali M, Dadkhah F, Sadrkhanlou M, Jamilian M, Ahmadi S, Tajabadi-Ebrahimi M, Jafari P, Asemi Z (2016) Effects of probiotic supplementation on glycaemic control and lipid profiles in gestational diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Metab 42(4):234–241. https://doi.org/10.1016/j.diabet.2016.04.009CrossRefPubMed

65.

Babadi M, Khorshidi A, Aghadavood E, Samimi M, Kavossian E, Bahmani F, Mafi A, Shafabakhsh R, Satari M, Asemi Z (2019) The effects of probiotic supplementation on genetic and metabolic profiles in patients with gestational diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Probiotics Antimicrob Proteins 11(4):1227–1235. https://doi.org/10.1007/s12602-018-9490-zCrossRefPubMed

66.

Saitoh S, Noda S, Aiba Y, Takagi A, Sakamoto M, Benno Y, Koga Y (2002) Bacteroides ovatus as the predominant commensal intestinal microbe causing a systemic antibody response in inflammatory bowel disease. Clin Diagn Lab Immunol 9(1):54–59. https://doi.org/10.1128/cdli.9.1.54-59.2002CrossRefPubMedPubMedCentral

67.

Johnson-Henry KC, Abrahamsson TR, Wu RY, Sherman PM (2016) Probiotics, prebiotics, and synbiotics for the prevention of necrotizing enterocolitis. Adv Nutr 7(5):928–937. https://doi.org/10.3945/an.116.012237CrossRefPubMedPubMedCentral

68.

Nabhani Z, Hezaveh SJG, Razmpoosh E, Asghari-Jafarabadi M, Gargari BP (2018) The effects of synbiotic supplementation on insulin resistance/sensitivity, lipid profile and total antioxidant capacity in women with gestational diabetes mellitus: a randomized double blind placebo controlled clinical trial. Diabetes Res Clin Pract 138:149–157. https://doi.org/10.1016/j.diabres.2018.02.008CrossRefPubMed

69.

Ahmadi S, Jamilian M, Tajabadi-Ebrahimi M, Jafari P, Asemi Z (2016) The effects of synbiotic supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes: a randomised, double-blind, placebo-controlled trial. Br J Nutr 116(8):1394–1401. https://doi.org/10.1017/S0007114516003457CrossRefPubMed

70.

Karamali M, Nasiri N, Taghavi Shavazi N, Jamilian M, Bahmani F, Tajabadi-Ebrahimi M, Asemi Z (2018) The effects of synbiotic supplementation on pregnancy outcomes in gestational diabetes. Probiotics Antimicrob Proteins 10(3):496–503. https://doi.org/10.1007/s12602-017-9313-7CrossRefPubMed

71.

Masulli M, Vitacolonna E, Fraticelli F, Della Pepa G, Mannucci E, Monami M (2020) Effects of probiotic supplementation during pregnancy on metabolic outcomes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Res Clin Pract 162:108111. https://doi.org/10.1016/j.diabres.2020.108111CrossRefPubMed

72.

Taylor BL, Woodfall GE, Sheedy KE, O’Riley ML, Rainbow KA, Bramwell EL, Kellow NJ (2017) Effect of probiotics on metabolic outcomes in pregnant women with gestational diabetes: a systematic review and meta-analysis of randomized controlled trials. Nutrients. https://doi.org/10.3390/nu9050461CrossRefPubMedPubMedCentral

73.

Pellonpera O, Mokkala K, Houttu N, Vahlberg T, Koivuniemi E, Tertti K, Ronnemaa T, Laitinen K (2019) Efficacy of fish oil and/or probiotic intervention on the incidence of gestational diabetes mellitus in an at-risk group of overweight and obese women: a randomized, placebo-controlled, double-blind clinical trial. Diabetes Care 42(6):1009–1017. https://doi.org/10.2337/dc18-2591CrossRefPubMed

74.

Mahizir D, Briffa JF, Wood JL, Anevska K, Hill-Yardin EL, Jefferies AJ, Gravina S, Mazzarino G, Franks AE, Moritz KM, Wadley GD, Wlodek ME (2020) Exercise improves metabolic function and alters the microbiome in rats with gestational diabetes. FASEB J 34(1):1728–1744. https://doi.org/10.1096/fj.201901424RCrossRefPubMed

75.

Rajilic-Stojanovic M, Vos DWM (2014) The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev 38(5):996–1047. https://doi.org/10.1111/1574-6976.12075CrossRefPubMed

76.

Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, Knight R (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 107(26):11971–11975. https://doi.org/10.1073/pnas.1002601107CrossRefPubMedPubMedCentral

77.

Ponzo V, Fedele D, Goitre I, Leone F, Lezo A, Monzeglio C, Finocchiaro C, Ghigo E, Bo S (2019) Diet-gut microbiota interactions and gestational diabetes mellitus (gdm). Nutrients. https://doi.org/10.3390/nu11020330CrossRefPubMedPubMedCentral

Titel: Impacts of gut microbiota on gestational diabetes mellitus: a comprehensive review
verfasst von: Lingling Huang
Chanisa Thonusin
Nipon Chattipakorn
Siriporn C. Chattipakorn
Publikationsdatum: 29.01.2021
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nutrition / Ausgabe 5/2021
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-021-02483-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Abstract

Background

Aim

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2021

Association of low plasma antioxidant levels with all-cause mortality and coronary events in healthy middle-aged men from France and Northern Ireland in the PRIME study

Daily vitamin D3 in overweight and obese children and adolescents: a randomized controlled trial

The relationship between dietary patterns and grip strength in the general population: the TCLSIH cohort study

100% Fruit juice intake and cardiovascular risk: a systematic review and meta-analysis of prospective and randomised controlled studies

Altered nutrition behavior during COVID-19 pandemic lockdown in young adults